Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Ji, Danan Li, Liang Chen, T. Shimamura, Susumu Kobayashi, K. McNamara, U. Mahmood, A. Mitchell, Yangping Sun, R. Al-Hashem, L. Chirieac, R. Padera, R. Bronson, William Kim, P. Jänne, G. Shapiro, D. Tenen, B. Johnson, R. Weissleder, N. Sharpless, Kwok-kin Wong (2006)
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies.Cancer cell, 9 6
J. Quinn, R. Kennedy, P. Mullan, Paula Gilmore, M. Carty, P. Johnston, D. Harkin (2003)
BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.Cancer research, 63 19
R. Lilenbaum, J. Herndon, M. List, C. Desch, D. Watson, Antonius Miller, S. Graziano, M. Perry, W. Saville, P. Chahinian, J. Weeks, J. Holland, Mark Green (2005)
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730).Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 1
M. Bergqvist, Svene Sörenson, D. Brattström, T. Mok, R. Henriksson (2006)
Role of Non-Taxane-Containing Chemotherapy in Advanced Non-Small Cell Lung CancerAmerican Journal of Cancer, 5
A. Sandler, J. Nemunaitis, C. Denham, J. Pawel, Y. Cormier, U. Gatzemeier, K. Mattson, C. Manegold, M. Palmer, A. Gregor, B. Nguyen, C. Niyikiza, L. Einhorn (2000)
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 1
L. Crinò, G. Scagliotti, S. Ricci, F. Marinis, M. Rinaldi, C. Gridelli, A. Ceribelli, R. Bianco, M. Marangolo, F. Costanzo, M. Sassi, S. Barni, A. Ravaioli, V. Adamo, L. Portalone, G. Cruciani, A. Masotti, G. Ferrara, F. Gozzelino, M. Tonato (1999)
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 17 11
V. Georgoulias, A. Ardavanis, A. Agelidou, M. Agelidou, V. Chandrinos, E. Tsaroucha, M. Toumbis, C. Kouroussis, K. Syrigos, A. Polyzos, N. Samaras, P. Papakotoulas, C. Christofilakis, N. Ziras, A. Alegakis (2004)
Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 22 13
R. Rosell, K. Danenberg, V. Alberola, G. Bepler, J. Sánchez, C. Camps, M. Provencio, D. Isla, M. Taron, P. Diz, Á. Artal (2004)
Ribonucleotide Reductase Messenger RNA Expression and Survival in Gemcitabine/Cisplatin-Treated Advanced Non-Small Cell Lung Cancer PatientsClinical Cancer Research, 10
U. Gatzemeier, J. Pawel, M. Gottfried, G. Velde, K. Mattson, Filipo DeMarinis, P. Harper, F. Salvati, G. Robinet, A. Lucenti, J. Bogaerts, G. Gallant (2000)
Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 19
M. Tummala, M. Edelman (2006)
Role of Non-Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung CancerAmerican Journal of Cancer, 5
K. Politi, M. Zakowski, P. Fan, Emily Schonfeld, W. Pao, H. Varmus (2006)
Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors.Genes & development, 20 11
G. Giaccone, T. Splinter, C. Debruyne, G. Kho, P. Lianes, N. Zandwijk, M. Pennucci, G. Scagliotti, J. Meerbeeck, Q. Hoesel, D. Curran, T. Sahmoud, P. Postmus (1998)
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 6
G. Fisher, Shari Wellen, D. Klimstra, J. Lenczowski, J. Tichelaar, M. Lizak, J. Whitsett, A. Koretsky, H. Varmus (2001)
Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.Genes & development, 15 24
Am J Cancer 2006; 5 (4): 211-212 COMMENTARY 1175-6357/06/0004-0211/$39.95/0 © 2006 Adis Data Information BV. All rights reserved. Optimizing Chemotherapy in Non-Small Cell Lung Cancer Rafael Rosell Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain The readers will enjoy the exhaustive review on non-platinum- genes between platinum and antimicrotubule drugs has been fully [1] [9] based chemotherapy in NSCLC by Tummala and Edelman, as reported. The clinical interpretation is that patients whose tu- well as the extensive data on non-taxane-based chemotherapy also mors have low levels of DNA repair genes, such as BRCA1 or [2] in NSCLC, by Bergqvist et al., both published in this issue of the ERCC1, could have a better response and survival with single Journal. Both articles are welcome since they contain comprehen- agents such as cisplatin or cisplatin plus gemcitabine, the latter a sive information on all types of clinical trials that have been neutral drug that is not influenced by BRCA1, while patients published in the field of NSCLC in recent years; hundreds of whose tumors display high levels of DNA repair genes could be studies showing the clinical outcomes of different platinum and more resistant to cisplatin while being
American Journal of Cancer – Springer Journals
Published: Aug 9, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.